Sinopharm Group Co. Ltd.
SHTDY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $47 | $54 | $43 | $64 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $244 | $207 | $242 | $186 |
| Inventory | $66 | $62 | $69 | $60 |
| Other Curr. Assets | $17 | $24 | $28 | $27 |
| Total Curr. Assets | $374 | $347 | $382 | $337 |
| Property Plant & Equip (Net) | $16 | $20 | $20 | $20 |
| Goodwill | $6 | $6 | $0 | $7 |
| Intangibles | $4 | $5 | $10 | $3 |
| Long-Term Investments | $11 | $11 | $11 | $11 |
| Tax Assets | $0 | $2 | $0 | $0 |
| Other NC Assets | $10 | $1 | $6 | $6 |
| Total NC Assets | $46 | $45 | $47 | $47 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $420 | $393 | $430 | $383 |
| Liabilities | – | – | – | – |
| Payables | $153 | $157 | $156 | $155 |
| Short-Term Debt | $86 | $64 | $81 | $57 |
| Tax Payable | $0 | $0 | $0 | $3 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $41 | $29 | $46 | $27 |
| Total Curr. Liab. | $280 | $250 | $283 | $241 |
| LT Debt | $7 | $12 | $20 | $17 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $1 |
| Other NC Liab. | $4 | $4 | $4 | $3 |
| Total NC Liab. | $11 | $16 | $24 | $22 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $5 | $5 | $5 |
| Total Liabilities | $291 | $266 | $307 | $263 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | $57 | $54 | $50 | $49 |
| AOCI | $0 | $22 | $22 | $0 |
| Other Equity | $20 | -$0 | -$0 | $22 |
| Total Equity | $80 | $79 | $76 | $75 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $49 | $48 | $47 | $46 |
| Total Liab. & Tot. Equity | $420 | $393 | $430 | $383 |
| Net Debt | $46 | $22 | $58 | $10 |